Charles N. York II - Jul 8, 2022 Form 4 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
COO, CFO and Secretary
Signature
/s/ Charles N. York II
Stock symbol
DAWN
Transactions as of
Jul 8, 2022
Transactions value $
-$28,320
Form type
4
Date filed
7/12/2022, 07:31 PM
Previous filing
Jul 6, 2022
Next filing
Jul 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DAWN Common Stock Sale -$28.3K -1.42K -0.42% $20.00 334K Jul 8, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2021.